Currently up %151 because of @TheLongInvest call out and it has so much more room to run!
$OSCR EARNINGS - Double Beat
+440% beat on estimates
TLI told you this was going to $45
The CEO told you this was going to $45
And this was at $10 this year because the market got it wrong
Now at $37
The way $GOOGL dropping you wouldn’t think I’d still be up 150%.
Waiting for the area to load the 🛥️
Trade finance is coming to the XRP Ledger!
Today, we’re expanding our collaboration with @BNYglobal across custody and tokenized trade finance, bringing BNY’s institutional scale together with $RLUSD, @XRP and the XRP Ledger.
→ on.ripple.com/4kkekDf
Again $XRP
Big news heading into @RippleSwell: the @USOCC has granted final approval for Ripple National Trust Bank.
This gives Ripple a federally supervised platform to support $RLUSD and provide digital asset custody to enterprises.
We’ve always said crypto and banks work better together — this is what that looks like. Real innovation, real accountability, federal oversight.
The revolution isn't happening outside the system. It's happening from within it.
$XRP The Standard, XRP.
And another use case. Listen to trolls & maxis all you want about $XRP. It will be the biggest bag you ever fumble in a dozen lifetimes.
RLUSD payments are becoming part of the banking infrastructure fintechs already use.
We’re partnering with @CrossRiverBank to integrate RLUSD on the XRP Ledger into its core banking platform, providing 24/7 settlement within payment networks and greater flexibility to settle intraday.
Learn more: crossriver.com/newsroom/cros…
Congratulations to our friends at @evernorthxrp on their Nasdaq debut!
Evernorth represents a new milestone for the XRP ecosystem, putting XRP to work via institutional strategies, and expanding with the network as new capabilities are introduced.
Proud to partner with Evernorth on this next chapter.
Added a stack of $ASTS at $49.68, close today at $50.97.
🚀
What’s a key to buying undervalued companies. Here’s 2:
1: Follow and turn on notifications to @TheLongInvest
2: Subscribe to his Patreon & block out the noise.
Digital Dividends retweeted
Today, I’m so proud to share that we're a strategic investor in Arboretum LifeSciences, a next-generation molecular information company. They’re combining genetic testing and AI to scale precision medicine to more conditions and more people.
Since meeting the Arboretum team, I have been looking for ways to be a part of getting their innovation into more hands for one simple reason. Giving people the tools to understand their risk before symptoms develop is how you transform a sickcare system into a healthcare system.
Understanding your own risk should be a normal part of care, not the exception. It’s the future of health that I believe in and it’s what Hims & Hers is all about. Health that gets smarter over time, adapts with you, and puts actionable information in your hands.
This goes beyond rare diseases and can fundamentally change how common conditions like heart disease, diabetes, and neurodegeneration are managed. Today, Arboretum is working with health systems and their providers, and I’m excited for the day that this kind of innovation extends beyond the traditional system (more to come here from us).
Congrats to Anthony, Clare, and the entire Arboretum team!
arboretum.bio/news/arboretum…
$OSCR Oscar is down -4.28% today, but the lesson is to buy undervalued companies and @TheLongInvest has nailed it.
Currently up 114..21% so today doesn’t put a dent & targets are still upwards!
Subscribing to @TheLongInvest analysis has hands down grounded my portfolio!
















